Is PFIZER INC (PFE) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 41.6% / 30% | 8.8% / 30% | 10.3% / 30% | 0.96% / 5% | ✗ NOT HALAL |
| DJIM | 41.6% / 33% | 8.8% / 33% | 10.3% / 33% | 0.96% / 5% | ✗ NOT HALAL |
| MSCI | 30.7% / 33% | 6.5% / 33% | 7.6% / 33% | 0.96% / 5% | ✓ HALAL |
| S&P | 41.6% / 33% | 8.8% / 33% | 10.3% / 33% | 0.96% / 5% | ✗ NOT HALAL |
| FTSE | 30.7% / 33% | 6.5% / 33% | 7.6% / 50% | 0.96% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 75.8% | |
| Operating Margin | 23.9% | |
| Net Margin | 12.4% | |
| Return on Equity (ROE) | 8.9% | |
| Return on Assets (ROA) | 5.7% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $11.7B |
| Free Cash Flow | $9.1B |
| Total Debt | $64.0B |
| Debt-to-Equity | 78.0 |
| Current Ratio | 1.2 |
| Total Assets | $208.2B |
Price & Trading
| Last Close | $27.57 |
| 50-Day MA | $26.81 |
| 200-Day MA | $25.39 |
| Avg Volume | 45.3M |
| Beta | 0.4 |
|
52-Week Range
$20.92
| |
About PFIZER INC (PFE)
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is PFIZER INC (PFE) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), PFIZER INC is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is PFIZER INC's debt ratio?
PFIZER INC's debt ratio is 41.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 30.7%.
What are PFIZER INC's key financial metrics?
PFIZER INC has a market capitalization of $153.8B, trailing P/E ratio of 19.9, and revenue of $62.6B. The company maintains a gross margin of 75.8% and a net margin of 12.4%. Return on equity stands at 8.9%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.